For patients with "good-risk" ductal carcinoma in situ (DCIS) who underwent breast-conserving surgery and did not receive ...

Patients with intermediate-risk breast cancer had similar rates of 10-year overall survival whether or not they underwent ...

ZTlido ® is a registered trademark owned by Scilex Pharmaceuticals Inc., a wholly-owned subsidiary of Scilex Holding Company. Gloperba ® is the subject of an exclusive, transferable license to use the ...

Follows Announcement Earlier this Week that Ampligen Co-Founder and Former AIM CEO Agreed to Join Scientific Advisory Board if Kellner Group Nominees Are Elected Kellner Group Reiterates Plan to ...

A randomized clinical trial in Iran exploring the effects of a low-calorie, high-protein diet on obese individuals found that ...

The company said the unanticipated events of pericardial effusion--when fluid builds up in the space around the heart--came in the Phase 2 clinical trial of 3 milligrams per kilogram and 4.6 mg/kg ...

The £100 million investment in the new CRDCs represents a major step in making cutting-edge treatments more accessible to ...

Stoke Therapeutics is nearing FDA sign-off on a groundbreaking Phase 3 clinical trial for its experimental drug for Dravet ...

The data is out there and has never been more important. Now, organizations must make efforts to access SDOH data, dive into ...

A new study led by investigators from Mass General Brigham has identified a unique brain network that links varied patterns of brain atrophy, or shrinkage, associated with schizophrenia.

At a time when fundamental questions are being posed about medical science, writes Jennifer Handt, let us not forget the beauty of it, the existential poetry and shared humanity that drives us toward ...

Recursion Pharmaceuticals is reshaping drug discovery with AI, strategic partnerships, and financial discipline for long-term ...